Blood neutrophil-lymphocyte ratio predicts survival after hepatectomy for hepatocellular carcinoma: A propensity score-based analysis
AIM: To investigate whether an elevated preoperative neutrophil-to-lymphocyte ratio(NLR) can predict poor survival in patients with hepatocellular carcinoma(HCC).METHODS: We retrospectively reviewed 526 patients with HCC who underwent surgery between 2004 and 2011.RESULTS: Preoperative NLR ≥ 2.81 wa...
Saved in:
Published in | World journal of gastroenterology : WJG Vol. 22; no. 21; pp. 5088 - 5095 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Baishideng Publishing Group Inc
07.06.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | AIM: To investigate whether an elevated preoperative neutrophil-to-lymphocyte ratio(NLR) can predict poor survival in patients with hepatocellular carcinoma(HCC).METHODS: We retrospectively reviewed 526 patients with HCC who underwent surgery between 2004 and 2011.RESULTS: Preoperative NLR ≥ 2.81 was an independent predictor of poor disease-free survival(DFS, P < 0.001) and overall survival(OS, P = 0.044). Compared with patients who showed a preoperative NLR < 2.81 and postoperative increase, patients who showed preoperative NLR ≥ 2.81 and postoperative decrease had worse survival(DFS, P < 0.001; OS, P < 0.001). Among patients with preoperative NLR ≥ 2.81, survival was significantly higher among those showing a postoperative decrease in NLR than among those showing an increase(DFS, P < 0.001; OS, P < 0.001). When elevated, alpha-fetoprotein(AFP) provided no prognostic information, and so preoperative NLR ≥ 2.81 may be a good complementary indicator of poor OS whenever AFP levels are low or high.CONCLUSION: Preoperative NLR ≥ 2.81 may be an indicator of poor DFS and OS in patients with HCC undergoing surgery. Preoperative NLR ≥ 2.81 may be a good complementary indicator of poor OS when elevated AFP levels provide no prognostic information. |
---|---|
Bibliography: | Hao-Jie Yang;Zhe Guo;Yu-Ting Yang;Jing-Hang Jiang;Ya-Peng Qi;Ji-Jia Li;Le-Qun Li;Bang-De Xiang;Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University;Department of General Surgery, the First People’s Hospital of Changde;Department of Thyroid and Breast Surgery, Central Hospital of Wuhan;Department of Oncology, the First People’s Hospital of Changde;Department of General Surgery, Second People’s Hospital of Jingmen;Guangxi Medical University ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Author contributions: Yang HJ, Guo Z and Yang YT contributed equally to this work; Xiang BD and Li LQ designed the research; Yang HJ, Guo Z, Yang YT and Qi YP performed the research; Yang HJ, Yang YT and Li JJ evaluated the clinic records and performed the statistical analyses; Yang HJ wrote the manuscript; all authors read and approved the final manuscript. Correspondence to: Bang-De Xiang, Professor, Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, 71 Hedi Road, Nanning 530021, Guangxi Zhuang Autonomous Region, China. yhj894924067@163.com Telephone: +86-771-5310045 Fax: +86-771-5312000 |
ISSN: | 1007-9327 2219-2840 |
DOI: | 10.3748/wjg.v22.i21.5088 |